FORMULATION DEVELOPMENT AND EVALUATION OF TEMOZOLOMIDE LOADED HYDROGENATED SOYA PHOSPHATIDYLCHOLINE LIPOSOMES FOR THE TREATMENT OF BRAIN CANCER

Authors

  • Bhavin K Patel Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Dist. Anand, 388421, Gujarat, India
  • Rajesh H Parikh Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Dist. Anand, 388421, Gujarat, India

Abstract

Objective: The objective of this study was to encapsulate temozolomide (TMZ) in the liposomal formulation for the treatment of glioblastoma. TMZ
is one of the most effective substances in vitro against cells derived from glioblastoma. However, it may not have a significant effect in vivo due to
poor penetration in brain which may be attributed to the blood-brain-barrier. The main objective of this investigation is to develop a liposomal drug
delivery system which could improve the brain targeting, and solve the treatment-related problems.
Methods: In this study, TMZ loaded liposomes were prepared by ethanol injection method. The characterization of formulated liposomes was carried
out by vesicle size, entrapment efficiency, surface morphology, and in vitro drug release study. The prepared liposomes were also evaluated for cell
uptake and cell cytotoxicity studies.
Results: Particle size and entrapment efficiency were found to be 105.7±3.9 nm and 78.25±0.98%, respectively. 75% of the entrapped drug was
released in 24 hrs from the selected liposomal formulation. Cell uptake study reveals that hydrogenated soya phosphatidylcholine (HSPC) loaded TMZ
liposomes interact with the glioblastoma cells and kill the cancer cells effectively. Cytotoxicity assay confirms that drug loaded HSPC liposomes are
more efficient with respect to killing of glioblastoma cells as compared to plain drug.
Conclusion: These results suggest that the TMZ loaded HSPC liposome may serve as a proficient targeted drug delivery system for the effective
management of glioblastoma.
Keywords: Temozolomide, Liposomes, Hydrogenated soya phosphatidylcholine, Cholesterol, Glioblastoma.

Downloads

Download data is not yet available.

Author Biographies

Bhavin K Patel, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Dist. Anand, 388421, Gujarat, India

Assistant Professor, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Dist. Anand, 388421, Gujarat, India

Rajesh H Parikh, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Dist. Anand, 388421, Gujarat, India

Professor and Principal, Ramanbhai Patel College of Pharmacy,

Dean Faculty of Pharmacy,

Charotar University of Science and Technology, CHARUSAT Campus, Changa, Dist. Anand, 388421, Gujarat, India

References

Béduneau A, Saulnier P, Benoit JP. Active targeting of brain tumors

using nanocarriers. Biomaterials 2007;28(33):4947-67.

Pardridge WM. Blood-brain barrier delivery. Drug Discov Today

;12(1-2):54-61.

Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier:

Development, composition and regulation. Vascul Pharmacol

;38(6):323-37.

Trinh VA, Patel SP, Hwu WJ. The safety of temozolomide in the

treatment of malignancies. Expert Opin Drug Saf 2009;8(4):493-9.

Fauchon F, Chiras J, Poisson M, Rose M, Terrier L, Bories J, et al.

Intra-arterial chemotherapy by cisplatin and cytarabine after temporary

disruption of the blood-brain barrier for the treatment of malignant

gliomas in adults. J Neuroradiol 1986;13(3):151-62.

Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for

therapeutic purposes: Osmotic opening and other means. Neurosurgery

;42(5):1083-99.

Lambert DM. Rationale and applications of lipids as prodrug carriers.

Eur J Pharm Sci 2000;11 Suppl 2:S15-27.

Bodor N, Buchwald P. Recent advances in the brain targeting of

neuropharmaceuticals by chemical delivery systems. Adv Drug Deliv

Rev 1999;36(3):229-54.

Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small

molecules using immunoliposomes. Proc Natl Acad Sci U S A

;93(24):14164-9.

Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid

nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev

;59(6):454-77.

Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. Polymeric

nanoparticles for the drug delivery to the central nervous system.

Expert Opin Drug Deliv 2008;5(2):155-74.

Schmitt-Sody M, Strieth S, Krasnici S, Sauer B, Schulze B, Teifel M,

et al. Neovascular targeting therapy: Paclitaxel encapsulated in

cationic liposomes improves antitumoral efficacy. Clin Cancer Res

;9(6):2335-41.

Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D.

Optimizing liposomes for delivery of chemotherapeutic agents to solid

tumors. Pharmacol Rev 1999;51(4):691-743.

Parmar JJ, Singh DJ, Hegde DD, Lohade AA, Soni PS, Samad A,

et al. Development and evaluation of inhalational liposomal system

of budesonide for better management of asthma. Indian J Pharm Sci

;72(4):442-8.

Lukyanov AN, Elbayoumi TA, Chakilam AR, Torchilin VP.

Tumor-targeted liposomes: Doxorubicin-loaded long-circulating

liposomes modified with anti-cancer antibody. J Control Release

;100(1):135-44.

Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H. Ethanol

injection method for hydrophilic and lipophilic drug-loaded liposome

preparation. J Liposome Res 2010;20(3):228-43.

Dua JS, Rana AC, Bhandari AK. Liposome: Methods of preparation

and applications. Int J Pharm Stud Res 2012;3:14-20.

Maruyama K. Intracellular targeting delivery of liposomal drugs to solid

tumors based on EPR effects. Adv Drug Deliv Rev 2011;63(3):161-9.

Torchilin V. Tumor delivery of macromolecular drugs based on the EPR

effect. Adv Drug Deliv Rev 2011;63(3):131-5.

Stockert JC, Blázquez-Castro A, Cañete M, Horobin RW, Villanueva A.

MTT assay for cell viability: Intracellular localization of the formazan

product is in lipid droplets. Acta Histochem 2012;114(8):785-96.

Parikh R, Dalwadi S, Aboti P, Patel L. Inhaled microparticles of

antitubercular antibiotic for in vitro and in vivo alveolar macrophage

targeting and activation of phagocytosis. J Antibiot (Tokyo)

;67(5):387-94.

Shmeeda H, Mak L, Tzemach D, Astrahan P, Tarshish M, Gabizon A.

Intracellular uptake and intracavitary targeting of folate-conjugated

liposomes in a mouse lymphoma model with up-regulated folate

receptors. Mol Cancer Ther 2006;5(4):818-24.

Steichen SD, Caldorera-Moore M, Peppas NA. A review of current

AQ4

Asian J Pharm Clin Res, Vol 9, Issue 3, 2016, 340-344

Patel and Parikh

nanoparticle and targeting moieties for the delivery of cancer

therapeutics. Eur J Pharm Sci 2013;48(3):416-27.

Patel BK, Parikh RH, Aboti PS. Development of oral sustained release

rifampicin loaded chitosan nanoparticles by design of experiment.

J Drug Deliv 2013;2013:370938.

???

Published

01-05-2016

How to Cite

Patel, B. K., and R. H. Parikh. “FORMULATION DEVELOPMENT AND EVALUATION OF TEMOZOLOMIDE LOADED HYDROGENATED SOYA PHOSPHATIDYLCHOLINE LIPOSOMES FOR THE TREATMENT OF BRAIN CANCER”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 3, May 2016, pp. 340-4, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/11459.

Issue

Section

Original Article(s)